Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzira 2012/2013 influenza vaccine immunogenicity and safety study in adults and older adults
2012-001101-24Phase 4Completed
- Sponsor
- CSL Limited
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of omeprazole in influenza (2 arms), sponsored by CSL Limited. Primary endpoint: Seroconversion or significant increase in antibody titre. Started Apr 2012; status: completed.
02
Drugs
omeprazole
03
Conditions
influenza
Beyond the preview
Go deeper on 2012-001101-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001101-24.